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Abstract

Introduction

Matrix vesicles are fundamental components of
initial mineral formation in endochondral and primary
ossification. Regulation of their structure and function
is multi-faceted and involves genomic and nongenomic
pathways. Their function in mineralization may include
matrix maturation and conveying cellular signals to the
extracellular matrix as well. Intravesicular hydroxyapatite crystal formation is associated with primary mineralization; subsequent crystal formation, particularly at
later stages, appears to be mediated by other mechanisms.

Primary mineralization is regulated by chondrocytes,
osteoblasts, and odontoblasts and is observed in epiphyseal cartilage, embryonic bone, post-fetal ossification, and repair and development of predentine, and
bone induction. In all these instances a tight regulation
of the process in both time and space is required.
Intravesicular crystals are seen prior to bulk phase
mineral deposition, suggesting that matrix vesicles have
a role in the initiation of calcification [1, 2, 8, 17, 59,
72]. While mineral crystals are first seen in matrix vesicles [3, 8, 14, 15, 72] it is unlikely that bulk phase mineral deposition requires vesicles or their constituents
[35]. However, the involvement of matrix vesicles is
believed to be an important factor in maintaining calcification cellular control. How this is accomplished will
be discussed below.
The accepted method for isolation of matrix vesicles
is by collagenase digestion of the calcifying tissue, followed by differential centrifugation [1, 4, 72, 74].
However, for frozen samples or tissues which are heterogeneous, this is not a useful approach. For these latter
instances, tissue homogenization followed by density
gradient centrifugation was found to be preferable [12,
30]. Using both differential centrifugation and/or density gradient centrifugation techniques, a number of biochemical characteristics of matrix vesicles have been
identified. Matrix vesicles have lipid compositions distinct from the cell in general [47, 71] and from the
plasma membrane [38, 60, 74]. Alkaline phosphatase,
long associated with calcification [69] is the organelle's
marker enzyme [2, 9, 43]. Matrix vesicles continue to
mature concomitant with maturation of the growth plate;
for instance, their mineral ion composition changes [74]
and proteolipid [22] and Ca-phospholipidphosphatecomplex (CPLX) content [73] increases. Their composition
and enzyme activity was shown to be regulated by hormones known to regulate calcification [25].
Although isolated matrix vesicles support hydroxyapatite formation in vitro [9, 72], a critical question in
the biogenesis of matrix vesicles has been whether or not
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Figure 1: Transmission electron
micrograph photographed from
television monitor to demonstrate
the method for morphometric
quantitationof extracellular matrix
vesicles in healing bone. Typing
and measurement of diameter and
distance from the calcified front is
performed by vesicular detection
with a pointing device ( +) to encircle their outline and delineation
of the calcified front (arrow).
Transopaque matrix vesicle is
indicated by an arrowhead and
transparent matrix vesicle by an
open arrowhead. Photo width =
5.7 µ.m.

itored as a function of time in perfusion-fixed tissue
using computerized cytomorphometry [59, 60]. Matrix
vesicles were sorted according to their type, diameter
and distance from the calcified front [5, 6, 54, 59, 60,
62, 63]. Electron lucent vesicles were categorized as
"empty"; those with amorphous electron opaque contents
as "amorphous" ; those containing crystalline structures
as "crystalline"; and those with ruptured membranes and
released crystals as "rupture" (Fig. 1).
These studies supported the hypothesis that cells are
responsible for the production of electron lucent vesicles
that continue to accumulate Ca and inorganic phosphorous (Pi), and acquire "amorphous-type" characteristics.
Hydroxyapatite crystals form, followed by membrane
rupture and exposure of the crystals to the matrix. Most
vesicles were found within 3 µ.m from the calcified
front. "Rupture" vesicles were closest to the front and
had the largest diameter [59]. Matrix vesicle maturation
on each day of healing was characterized by increased
vesicular diameter and was accompanied by increased
numbers of mature vesicles of the "crystal" and "rupture" types and decreased numbers of the "empty" and
"amorphous" types [59].
Changes in matrix vesicle morpbometry correlate
with biochemical changes in matrix vesicle-enriched
microsomal fractions (MVEM) isolated from the healing
tissue. At six days post-injury, there is an increase in
MVEM alkaline phosphatase and phospholip~ A2 specific activities (Fig. 2) [57]. Phospholipid composition
changes with time. The amount of phosphatidylcholine
decreases as a function of time. Phosphatidylserine content is greatest at days 6 and 14, which correlates with

they are "preloaded" with calcium and phosphate at the
time of their release. Specific interactions of Ca2 + and
phosphate ions with phospholipids in the cell membrane
could result in the formation of CPLX [28] . Phospholipid-mineral interactions may be responsible for membrane fusion, allowing vesicular budding into the extracellular matrix [37, 72] . The occurrence of actin in isolated vesicle fractions is indicative of a cytoskeletal role
in vesicle formation as well [45, 61, 72].
Whether multiple subclasses of matrix vesicles are
produced by a single cell at a specific stage of differentiation or whether each cell produces only one class of
vesicle is unknown. The continuing maturation of the
vesicles in the extracellular matrix could also add to
their apparent heterogeneity. Immediately after release,
vesicles appear electron lucent, although Ca and phosphate may already be present. Following further uptake
of calcium and phosphate, vesicle morphology is amorphous, homogeneous, and electron-opaque. Calcification
on the internal surface of the membrane follows . Rupture of the vesicular membrane follows crystal growth.
In the matrix, released crystals adhere to each other and
serve as foci for continued crystal deposition, and
calcospherite formation [59].

Changes in Matrix Vesicle Morphology and
Biochemistry in Bone Healing
Removal of the marrow tissue in rat tibial bone has
been developed as an animal model of primary mineralization during bone healing. Following injury, endosteal
bone formation is activated. This process has been mon154
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Figure 2: Specific activities of alkaline phosphatase expressed as µmol P/mg protein/minute and phospholipase A2
expressed as percent hydrolysis/mg protein/minute in matrix vesicle-enriched membranes isolated from tibial bone healing following marrow ablation. Isolation is performed by differential centrifugation of homogenates of the newly
formed tissues. Values are presented as means ± standard error of mean (S.E.M.) for six samples, each sample composed of pooled tissue of six animals. *: statistically significant; p < 0.05 for each time point compared to time 0.

the onset of calcification in the tissue and may reflect its
role in the initiation of hydroxyapatite formation as a
constituent of matrix vesicle proteolipids and CPLX.
Matrix vesicle morphometrics and MVEM biochemical parameters are sensitive to regulation in vivo.
When bone-bonding and non-bonding ceramic and metal
implants were inserted into the marrow-ablated tibia,
changes were observed in the normal healing pattern,
both in the treated leg and in MVEM isolated from the
contralateral limb [7, 44, 53]. Bone-bonding materials
stimulated MVEM alkaline phosphatase specific activity
and increased matrix vesicle density in the treated limb
at early time points. While MVEM alkaline phosphatase
behaved like that seen in normal healing at later times,
matrix vesicle concentration (#/µm 2) was decreased with
respect to normal. MVEM phospholipase A2 specific
activity was lower in tissue adjacent to the bone-bonding
implants and was markedly inhibited in the contralateral
limb.

The implant-dependent decrease in MVEM phospholipase A2 activity was even more marked in the tissue
adjacent to nonbonding implants; there was no MVEM
phospholipase A2 activity in the contralateral limb.
MVEM alkaline phosphatase specific activity became
only slightly elevated during healing, but no differences
in magnitude between treatment and control limbs were
evident. Matrix vesicle density was either comparable
to that of normal healing bone or was depressed. These
data demonstrate that there is both local and systemic
regulation involved.

Role of Matrix Vesicle Components in
Mineral Deposition
The data presented above show that changes in alkaline phosphatase or phospholipase A2 activities can be
correlated with altered matrix vesicle function in vivo.
Other components of the vesicle are now known to play
a role in the calcification process. Most information is
155
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derived from studies of cartilage and cartilage cells. Initial sites of hydroxyapatite deposition are observed on
the inner vesicle membranes [1-3, 9]. CPLX and proteolipids, shown to support calcification in vitro [16, 17,
23, 50], have been isolated from matrix vesicles [23,
73], suggesting that they could function as mineralization
initiation sites. Other observations support this hypothesis. CPLX is present at sites where mineralization is
about to occur or has just started, as evidenced in hypertrophic cartilage, metaphyseal bone, fracture callus, and
following induction of heterotopic bone formation [10,
16-20]. Proteolipids are enriched in matrix vesicles and
participate in formation of CPLX, in part by structuring
phosphatidylserine [21, 22]. Proteolipids may also act
as ionophores, exporting protons and importing calcium
and phosphate [27, 68].
Enzymes like alkaline phosphatase, pyrophosphatase, ATPase, phospholipase A2 , and NTP-pyrophosphohydrolase, which exhibit increased activity as the growth
plate mineralizes, have been localized to matrix vesicles
[32, 33, 38, 70] and are regulated by factors which
monitor calcification [24, 55, 56, 58]. Robison [52]
first observed the relationship between bone formation
and increased alkaline phosphatase and postulated a role
in raising local concentrations of Pi [9, 40]. It is possible that more than one matrix vesicle alkaline phosphatase exists [11], each with a distinct function.
Other matrix vesicle proteins appear to play a role
in calcification. Uptake of mineral ions by isolated
matrix vesicles incubated in synthetic cartilage lymph
has been shown to follow a consistent pattern. After an
initial lag, vesicles rapidly accumulated ea2+ and Pi, an
ability readily destroyed by proteases. A subset of
EGTA-extractable proteins selectively bound Ca2 + in the
presence of lipids and cross-reacted with antibodies to
calpactin II, suggesting that this protein was involved in
ion uptake [34].
Matrix maturation is important in the cascade of extracellular events which lead to bulk phase hydroxyapatite formation. Mineralization of the matrix involves
proteoglycan degradation [26, 32, 41, 42], including aggregate breakdown, proteolysis of the core protein, and
glycosaminoglycan degradation [48, 49]. Cytochemical
studies [71] suggest that glycosaminoglycan loss is mediated by matrix vesicles. Proteases are present in matrix
vesicles [29, 38], suggesting that they participate in
matrix processing. Their distribution is cell maturationdependent; neutral and acid metalloproteinase activity is
highest in matrix vesicles produced by growth zone
chondrocytes [29]. Since a significant percentage of the
metalloproteinases are in active form, breakdown of the
matrix vesicle may be the event which releases these
enzymes for matrix maturation and subsequent calcification.

Regulation of Matrix Vesicle Mineral Formation
Membrane phospholipids are subject to regulation
by a number of enzymes; thus, their metabolism can influence the structure and function of matrix vesicles (39,
64-66]. Phospholipase A2 activity increases commensurate with maturation of the growth plate (70]. In matrix
vesicles isolated from cultured chondrocytes, enzyme activity is higher in growth vesicles produced by growth
zone cells than in vesicles produced by resting zone cells
[55]. This enzyme catalyzes the rate-limiting step in
prostaglandin production [13, 36], and is also required
for fatty acid turnover, resulting in changes in membrane fluidity. This can have consequences for ion
transport and enzyme activity (46, 51]. The fluidity of
the membrane can alter its structural characteristics (31]
ultimately changing the ability to support mineralization.
Another role for phospholipases in vesicles may be to
degrade membrane phospholipids, resulting in loss of
vesicle integrity [67, 72]. Those lipids which have
formed mineral complexes appear to be resistant to the
action of phospholipases [50]. This may explain the
difference in susceptibility to hydrolysis observed when
phospholipids isolated from plasma membranes or matrix
vesicles are incubated with exogenous phospholipases
[58].
Other matrix vesicle enzymes may play roles in removal of mineralization inhibitors (32]. ATP and other
nucleotide triphosphates are present in matrix vesicles
and inhibit crystal growth. Their hydrolysis by NTPpyrophosphohydrolase (32] generates pyrophosphate, another polyphosphate inhibitor, subsequently degraded by
pyrophosphatase. As hydrox yapatite crystals grow, protons are released, potentially lowering local pH. One
function of matrix vesicle carbonic anhydrase may be to
prevent this acidification. Other proteins are present,
such as actin [45] but probably do not have a role in
mineral deposition.
The suggested chain of events and their localization
in the extracellular matrix, on the vesicular membrane,
and within its lumen support the current hypothesis on
the active role of matrix vesicles in the initiation of
mineralization (Fig. 3).
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such that mineralization may proceed. Have the authors
considered the possibility that these matrix-vesicle
associated proteases may also be involved in the binding
or activation of growth factors or cytokines?
Authors: Dr. Einhorn raises an interesting point. Preliminary data from our laboratory suggest that matrix
vesicle enzymes do play a role in activation of cytokines
in the matrix.
T .A. Einhorn: The authors imply that the lipid content
of matrix vesicles is distinct from the cell in general and
the plasma membrane. If this is true, what is the origin
of the matrix vesicle in relation to the cell? How does
it form? Is its trilaminar membrane similar to that found
in chondrocytes or osteoblasts or is it unique to the
matrix vesicle?
Authors: The phospholipid composition of matrix vesicles differs quantitatively from that of the plasma membrane from which it is derived. This may be due to
formation of specific phospbolipid domains prior to the
release of the matrix vesicle from the plasma membrane.
Another mechanism may be phospholipid metabolism in
the matrix vesicle itself.
T.A. Einhorn: Various investigators have suggested
that matrix vesicles are nothing other than artifacts of
tissue preparation. What evidence do the authors have
that this is not the case and that matrix vesicles are true
physiological entities?
Authors: In early descriptions of matrix vesicles they
were compared biochemically to the chondrocyte pellet.
Not surprisingly, they exhibited enrichment of alkaline
phosphatase since they represented a relatively pure population of membranes and the plasma membrane alkaline
phosphatase of the cell was diluted by other cellular
constituents. This may have led to some of the confusion concerning the concept of matrix vesicles as "dynamic cell debris" versus a legitimate extracellular
organelle. In our studies, matrix vesicles are compared
to purified plasma membranes. Because they are extracellular, homogenization of the tissue is not needed for
their isolation following enzymatic degradation of the
extracellular matrix. They can be easily separated from
the cells by gently pelleting the latter. The cells are
more than 95 % viable by trypan blue dye exclusion suggesting that fragmentation of the plasma membrane is
minimal. The matrix vesicles isolated in this manner are
"right side out." It is necessary to homogenize the cells
in order to purify the plasma membranes. When the
plasma membranes are isolated, they may be inside out
or right side out. If matrix vesicles were fragments of
the plasma membrane, they would also be one-half inside out and one-half outside out and alkaline phosphatase activity would equal that of the plasma membrane.
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Reviewer I: Matrix vesicles are extracellular - how can
they keep calcification under cell control?
Authors: Recent studies have shown that matrix vesicles are under autocrine regulation by chondrocytes.
These cells produce vitamin D metabolites which have
direct, nongenomic effects on the matrix vesicle membrane. In effect, the cell is able to regulate events in the
matrix by remote control. While l ,25-(0H)iD3 and
24,25-(0H)iD 3 have comparable effects on isolated
matrix vesicles and plasma membranes, the effects are
seen only in the matrix vesicles and not in the plasma
membranes isolated from intact cells incubated with hormone. These data suggest that the cbondrocyte can
down regulate any effects on the cell, whereas, the
matrix vesicle is unable to do so. In this manner, the
cell is able to synthesize the matrix vesicle under
genomic control and then regulate its activity later by
nongenomic mechanisms.
T .A. Einhorn: The authors note that, in addition to
their role in mineralization, matrix vesicles may be
involved in various biochemical events which take place
during the degradation of proteoglycan aggregates.
These proteolytic activities are presumed to be necessary
in order to create the necessary biochemical environment
160
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If enrichment of enzyme activity were only two-fold,
positive identification would still not be possible, since
the vesicles could have been formed by trypsiniz.ation
and be right side out. For this reason, the alkaline phosphatase specific activity of the matrix vesicles must be
more than twice that of the plasma membranes
order
for them to be considered by us to be "true physiological
entities. " In many of our preparations, the alkaline
phosphatase specific activity of the matrix vesicles is ten
times that of the plasma membranes.
This quality control is not possible when using matrix vesicle-enriched microsomes prepared from homogenized tissue. In order to isolate the purest matrix vesicles possible, both differential and density gradient centrifugation are used. The matrix vesicles that are obtained using this methodology are comparable to the
ones that are obtained using the methods described
above. While it is not possible to rule out that we have
merely isolated an alkaline phosphatase-rich domain of
the plasma membrane, the similarity of the composition
of matrix vesicle-enriched microsomes with the matrix
vesicles isolated from enzymatically digested tissue,
argues that we have not.

subcellular membrane organelle, was quite low, based
on marker enzyme studies.
We chose not to use the plasma membrane fraction
because other studies in our laboratory have shown that
the plasma membrane is regulated in a differential manner from the matrix vesicles, and it was matrix vesicles
we were interested in based on our cytomorphometric
studies.

m

J.M. Shapiro: While it is very interesting that bone
cells secrete matrix vesicles and mineral is present in the
vesicles at sites of repair, mineral is also seen in collagen. Would the authors please provide some information on the relationship between matrix vesicle and collagen mineraliz.ation at these repair sites? In addition,
are values for matrix vesicle related to values obtained
for other components of the matrix?
Authors: Whether or not the mineral present in matrix
vesicles is directly related to mineral on the collagen
fibrils has not been satisfactorily resolved. It is our
hypothesis that the mineral within the vesicle is involved
in its breakdown and the subsequent release of proteases
needed to modify the matrix for bulk phase mineraliz.ation. At the transmission electron microscopy level, it
appears that at least some of the mineral present in the
matrix vesicles contributes to calcospherite formation.

J.M. Shapiro: It is difficult to understand why the
authors utilize a high speed fraction (MVEM), derived
from the tissue homogenate as a substitute for native matrix vesicles. The homogenate would contain many cell
types and, therefore, many different kind of vesicles
would be generated. Moreover, as the MVEM which is
mainly endoplasmic reticulum, it would have a different
lipid and protein composition from plasma membrane,
which in tum is different from that of the matrix vesicle.
Would it not be better to use either a plasma membrane
fraction or isolated vesicles for the studies described in
the manuscript?
Authors: We agree that the MVEM are not the fraction
of choice if one wants to study matrix vesicles. We
used MVEM because the tissues from which we isolated
them were frozen to permit transfer from Israel to the
USA. The result was freeze/thawed tissue, itself somewhat homogenized, and, therefore, classical matrix vesicle isolation techniques were precluded. A further complication was the difference in consistency in the tissues
with time. Homogeniz.ation eliminated some of the variation. Some confusion may result from the term "microsomes," which to many biochemists implies rough or
smooth endoplasmic reticulum. Certainly rough endoplasmic reticulum can be ruled out, as there is no RNA
present in the matrix vesicle preparation. Microsomes
can also refer to any membrane preparation that forms
vesicles under aqueous conditions. We are confident
that the MVEM were a highly enriched fraction and that
endoplasmic reticulum contamination, or of any other

J.M. Shapiro: The data on phospholipase activities at
mineralizing sites is of considerable interest. Why was
there inhibition of phospholipase activity in tissue close
to implants, etc.? Does this imply that there exists in
the extracellular matrix a local phospholipase inhibitor;
alternatively, does the implant modulate osteoblast endoplasmic reticulum enzyme activity (MVEM) and this results in modification in matrix vesicle lipase activity?
Authors: We are also intrigued by the regulation of
phospholipase A2 • We are presently examining the effects of specific phospholipase A2 activators and inhibitors to try to dissect the problem more effectively.
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